DMAA
$10.47-0.01 (-0.14%)
Market OpenAs of Mar 17, 4:08 PM UTC
Drugs Made In America Acquisition Corp.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$10.47
Potential Upside
5%
Whystock Fair Value$11.00
Price
UndervaluedFair ValueOvervalued
Fundamentals
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more b...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$351.09M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.00
